Brief: Xortx Announces Positive Topline Results From Pharmacokinetics Bridging Clinical Trial
13/07/2022 13:12
July 13 (Reuters) - XORTX Therapeutics Inc XRTX.V :
* XORTX ANNOUNCES POSITIVE TOPLINE RESULTS FROM
PHARMACOKINETICS
BRIDGING CLINICAL TRIAL
Source text for Eikon: ID:nGNX76N6hj
Further company coverage: XRTX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Outlines Anticipated Health Canada Clinical Trial Application For Xrx-026 For Gout
Brief: XORTX Therapeutics Announces Initiation Of Drug And Tablet Manufacturing For XRx-026 Program
Brief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering